LOGO
LOGO

Anebulo Pharmaceuticals, Inc. Loss At -$2.14 Mln In Q4

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

Anebulo Pharmaceuticals, Inc. (ANEB) reported Loss for fourth quarter of -$2.14 million

The company's earnings came in at -$2.14 million, or -$0.05 per share. This compares with -$1.35 million, or -$0.05 per share, last year.

Anebulo Pharmaceuticals, Inc. earnings at a glance (GAAP) :

-Earnings: -$2.14 Mln. vs. -$1.35 Mln. last year.
-EPS: -$0.05 vs. -$0.05 last year.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - May 04 – May 08, 2026

May 08, 2026 15:50 ET
Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.

Latest Updates on COVID-19